Am J Cardiol

1. MINAMI Y, Iwaya T
   Are Sodium-Glucose Cotransporter-2 Inhibitors Fantastic for Coronary Plaque Stabilization?
   Am J Cardiol. 2024;222:95.
   

   >> Share

   
   

   
   Ann Intern Med

2. CRAWFORD AL, Laiteerapong N
   Type 2 Diabetes.
   Ann Intern Med. 2024 Jun 11. doi: 10.7326/AITC202406180.
   

   >> Share

   
   
3. SMETANA GW, Romeo GR, Rosas SE, Burns RB, et al
   How Would You Manage This Patient With Type 2 Diabetes and Chronic Kidney Disease? Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
   Ann Intern Med. 2024 Jun 11. doi: 10.7326/M24-0764.
   

   >> Share

   
   

   
   Atherosclerosis

4. GAGNON E, Bourgault J, Gobeil E, Theriault S, et al
   Impact of loss-of-function in angiopoietin-like 4 on the human phenome.
   Atherosclerosis. 2024;393:117558.
   

   >> Share

   
   

   
   Biochem Biophys Res Commun

5. SHAHID M, Subhan F, Ahmad N, Din ZU, et al
   6-Methoxyflavone antagonizes chronic constriction injury and diabetes associated neuropathic nociception expression.
   Biochem Biophys Res Commun. 2024;724:150217.
   

   >> Share

   
   

   
   BMC Ophthalmol

6. YAO Y, Wang Q, Yang J, Yan Y, et al
   Associations of retinal microvascular alterations with diabetes mellitus: an OCTA-based cross-sectional study.
   BMC Ophthalmol. 2024;24:245.
   

   >> Share

   
   

   
   BMJ

7. YANG K, Yang X, Jin C, Ding S, et al
   Global burden of type 1 diabetes in adults aged 65 years and older, 1990-2019: population based study.
   BMJ. 2024;385:e078432.
   

   >> Share

   
   

   
   Diabet Med

8. MCKECHNIE V, Khan S, Saunders R, Amiel SA, et al
   Psychometric validation of the hyperglycaemia avoidance scale UK (HAS-UK).
   Diabet Med. 2024;41:e15342.
   

   >> Share

   
   
9. FRAMPTON R, Snaith JR, Hocking S, Holmes-Walker J, et al
   Reducing cardiometabolic risk with semaglutide in type 1 diabetes (RESET1): Study protocol of a phase 2 double-blinded randomised placebo-controlled trial.
   Diabet Med. 2024 Jun 9:e15377. doi: 10.1111/dme.15377.
   

   >> Share

   
   
10. PEERAWARANUN P, Pan-Ngum W, Hantrakun V, Wild SH, et al
    Diabetes and risk of hospitalisation due to infection in northeastern Thailand: Retrospective cohort study using population-based healthcare service data.
    Diabet Med. 2024 Jun 9:e15378. doi: 10.1111/dme.15378.
    

    >> Share

    
    
11. ROESLER A, Butten K, Taylor P, Morrison M, et al
    The experiences of individuals who have had gestational diabetes: A qualitative exploration.
    Diabet Med. 2024 Jun 9:e15374. doi: 10.1111/dme.15374.
    

    >> Share

    
    
12. HABTE-ASRES HH, Rosenthal M, Nitsch D, Wheeler DC, et al
    Closing the policy gap in diabetes care for individuals with advanced CKD.
    Diabet Med. 2024 Jun 10:e15381. doi: 10.1111/dme.15381.
    

    >> Share

    
    
13. BUCKLEY S, Subramaniam Y, Mallik R, Mukuba D, et al
    Efficacy and safety of sodium-glucose co-transporter-2 inhibitors in kidney transplant recipients with diabetes mellitus.
    Diabet Med. 2024 Jun 10:e15383. doi: 10.1111/dme.15383.
    

    >> Share

    
    
14. DE WIT M, van Luik S, Marrero D, Barnard-Kelly K, et al
    Person-reported outcomes in registered randomised diabetes trials: A mapping review of constructs.
    Diabet Med. 2024 Jun 14:e15385. doi: 10.1111/dme.15385.
    

    >> Share

    
    

    
    Diabetes

15. LESLIE KA, Lekka C, Richardson SJ, Russell MA, et al
    Regulation of STAT1 signalling in human pancreatic beta-cells by the lysine deacetylase, HDAC6; a new therapeutic opportunity in type 1 diabetes?
    Diabetes. 2024 Jun 13:db240008. doi: 10.2337/db24-0008.
    

    >> Share

    
    
16. MAO A, Li Z, Shi X, Zhang K, et al
    Complement factor C1q mediates vascular endothelial dysfunction in STZ-induced diabetic mice.
    Diabetes. 2024 Jun 13:db230981. doi: 10.2337/db23-0981.
    

    >> Share

    
    
17. ZEINI M, Laurenti MC, Egan AM, Muthusamy K, et al
    The longitudinal effect of Diabetes-associated variation in TCF7L2 on islet function in humans.
    Diabetes. 2024 Jun 13:db240192. doi: 10.2337/db24-0192.
    

    >> Share

    
    
18. WOLF SJ, Audu CO, Moon JY, Joshi AD, et al
    Diabetic wound keratinocytes induce macrophage JMJD3-mediated Nlrp3 expression via IL-1R signaling.
    Diabetes. 2024 Jun 13:db230968. doi: 10.2337/db23-0968.
    

    >> Share

    
    
19. FU Q, Song Y, Ling Z, Liu J, et al
    Regulatory Role of NF-kappaB on HDAC2 and Tau Hyperphosphorylation in Diabetic Encephalopathy and the Therapeutic Potential of Luteolin.
    Diabetes. 2024 Jun 13:db230969. doi: 10.2337/db23-0969.
    

    >> Share

    
    

    
    Diabetes Care

20. ROSSING P, Groop PH, Singh R, Lawatscheck R, et al
    Prevalence of Chronic Kidney Disease in Type 1 Diabetes Among Adults in the U.S.
    Diabetes Care. 2024 Jun 10:dc240335. doi: 10.2337/dc24-0335.
    

    >> Share

    
    
21. GHALWASH M, Anand V, Ng K, Dunne JL, et al
    Data-Driven Phenotyping of Presymptomatic Type 1 Diabetes Using Longitudinal Autoantibody Profiles.
    Diabetes Care. 2024 Jun 11:dc240198. doi: 10.2337/dc24-0198.
    

    >> Share

    
    
22. KARGER AB, Nasrallah IM, Braffett BH, Luchsinger JA, et al
    Plasma Biomarkers of Brain Injury and Their Association With Brain MRI and Cognition in Type 1 Diabetes.
    Diabetes Care. 2024 Jun 11:dc240229. doi: 10.2337/dc24-0229.
    

    >> Share

    
    
23. NINO DE RIVERA J, Albrecht SS
    Determinants of Diabetes Awareness Among Hispanic/Latino Adults in the U.S., 2005-2018.
    Diabetes Care. 2024 Jun 11:dc240520. doi: 10.2337/dc24-0520.
    

    >> Share

    
    
24. STONE SI, Balasubramanyam A, Posey JE
    Erratum. Atypical Diabetes: What Have We Learned and What Does the Future Hold? Diabetes Care 2024;47:770-781.
    Diabetes Care. 2024 Jun 11:dc24er09a. doi: 10.2337.
    

    >> Share

    
    
25. MCCARTER R, Chalew S
    Non-Hispanic Black Individuals Have Higher Glucose-Adjusted HbA1c Levels and Risk for Severe Hypoglycemia: Evidence From the Diabetes Control and Complications Trial.
    Diabetes Care. 2024 Jun 12:dc240299. doi: 10.2337/dc24-0299.
    

    >> Share

    
    

    
    Diabetes Obes Metab

26. TINTI D, Nobili C, Baretta I, Rosso A, et al
    Paediatric type 1 diabetes mellitus: A comparison between multi-injection therapy and advanced hybrid closed-loop pump in the first year after diabetes onset.
    Diabetes Obes Metab. 2024 Jun 11. doi: 10.1111/dom.15704.
    

    >> Share

    
    
27. WELK B, McClure JA, Carter B, Clarke C, et al
    No association between semaglutide and postoperative pneumonia in people with diabetes undergoing elective surgery.
    Diabetes Obes Metab. 2024 Jun 11. doi: 10.1111/dom.15711.
    

    >> Share

    
    
28. AL-ABDULLAH L, Ahern A, Welsh P, Logue J, et al
    A predictive model for medium-term weight loss response in people with type 2 diabetes engaging in behavioural weight management interventions.
    Diabetes Obes Metab. 2024 Jun 14. doi: 10.1111/dom.15706.
    

    >> Share

    
    
29. ZHOU Y, Xu M, Yin X, Gong Y, et al
    Association between new-onset atrial fibrillation and dementia among individuals with type 2 diabetes.
    Diabetes Obes Metab. 2024 Jun 14. doi: 10.1111/dom.15714.
    

    >> Share

    
    
30. KIM NH, Moon JS, Lee YH, Cho HC, et al
    Efficacy and tolerability of initial triple combination therapy with metformin, dapagliflozin and saxagliptin compared with stepwise add-on therapy in drug-naive patients with type 2 diabetes (TRIPLE-AXEL study): A multicentre, randomized, 104-week, o
    Diabetes Obes Metab. 2024 Jun 10. doi: 10.1111/dom.15705.
    

    >> Share

    
    
31. DEL PRATO S, Giorgino F, Szafranski K, Poon Y, et al
    Cost-utility analysis of a flash continuous glucose monitoring system in the management of people with type 2 diabetes mellitus on basal insulin therapy-An Italian healthcare system perspective.
    Diabetes Obes Metab. 2024 Jun 10. doi: 10.1111/dom.15703.
    

    >> Share

    
    
32. ZU C, Liu M, Wang G, Meng Q, et al
    Association between longitudinal changes in body composition and the risk of kidney outcomes in participants with overweight/obesity and type 2 diabetes mellitus.
    Diabetes Obes Metab. 2024 Jun 10. doi: 10.1111/dom.15699.
    

    >> Share

    
    
33. NAPOLI R, Nicolucci A, Larosa M, Rossi MC, et al
    Treatment intensification following glucagon-like peptide-1 receptor agonists in type 2 diabetes: Comparative effectiveness analyses between different basal insulins. RESTORE-G real-world study.
    Diabetes Obes Metab. 2024 Jun 10. doi: 10.1111/dom.15697.
    

    >> Share

    
    
34. TANG F, Wang W, Wang Y, Lee Y, et al
    Moderate resistance training reduces intermuscular adipose tissue and risk factors of atherosclerotic cardiovascular disease for elderly patients with type 2 diabetes.
    Diabetes Obes Metab. 2024 Jun 9. doi: 10.1111/dom.15684.
    

    >> Share

    
    
35. WINTHER JB, Holst JJ
    Glucagon agonism in the treatment of metabolic diseases including type 2 diabetes mellitus and obesity.
    Diabetes Obes Metab. 2024 Jun 9. doi: 10.1111/dom.15693.
    

    >> Share

    
    

    
    Diabetologia

36. MCNEILLY AD, Gallagher JR, Evans ML, de Galan BE, et al
    Correction: Chronic hyperglycaemia increases the vulnerability of the hippocampus to oxidative damage induced during post-hypoglycaemic hyperglycaemia in a mouse model of chemically induced type 1 diabetes.
    Diabetologia. 2024 Jun 12. doi: 10.1007/s00125-024-06188.
    

    >> Share

    
    

    
    Eur J Endocrinol

37. RIX I, Lund AB, Garvey LF, Hansen CP, et al
    Increased hepatic glucagon sensitivity in totally pancreatectomised patients.
    Eur J Endocrinol. 2024;190:446-457.
    

    >> Share

    
    

    
    Hypertension

38. SANTULLI G, Visco V, Varzideh F, Guerra G, et al
    Prediabetes Increases the Risk of Frailty in Older Adults With Prefrail Hypertension: Beneficial Effects of Metformin.
    Hypertension. 2024 May 16. doi: 10.1161/HYPERTENSIONAHA.124.23087.
    

    >> Share

    
    

    
    Invest Ophthalmol Vis Sci

39. TSAI HR, Lin YJ, Yeh JI, Lin SM, et al
    Use of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients With Type 2 Diabetes and the Incidence of Retinal Vein Occlusion in Taiwan.
    Invest Ophthalmol Vis Sci. 2024;65:19.
    

    >> Share

    
    

    
    J Am Coll Cardiol

40. PINNEY SP, Costanzo MR
    As Good as it Gets: SGLT2 Inhibitors in Cardiac Amyloidosis.
    J Am Coll Cardiol. 2024;83:2423-2425.
    

    >> Share

    
    

    
    J Clin Endocrinol Metab

41. LIU S, Tham WK, Lee J, Ang K, et al
    Plasma ceramides predict all-cause and cause-specific mortality in individuals with type 2 diabetes.
    J Clin Endocrinol Metab. 2024 Jun 8:dgae388. doi: 10.1210.
    

    >> Share

    
    
42. VITALE RJ, Tinsley LJ, Volkening LK, Laffel LM, et al
    Lower Independent Self-Care Readiness Persists over Time in Teens with Type 1 Diabetes and Executive Function Challenges.
    J Clin Endocrinol Metab. 2024 Jun 12:dgae391. doi: 10.1210.
    

    >> Share

    
    
43. KJAERGAARD AD, Ellervik C, Jessen N, Lessard SJ, et al
    Cardiorespiratory fitness, body composition, diabetes, and longevity: a two-sample Mendelian randomization study.
    J Clin Endocrinol Metab. 2024 Jun 12:dgae393. doi: 10.1210.
    

    >> Share

    
    
44. CALVIGIONI M, Biancalana E, Mazzantini D, Celandroni F, et al
    In-depth microbiological characterization of urine from subjects with type 2 diabetes.
    J Clin Endocrinol Metab. 2024 Jun 13:dgae389. doi: 10.1210.
    

    >> Share

    
    
45. DI FILIPPO L, Giustina A
    Vitamin D deficiency and type 2 diabetes: the dangerous link between two modern pandemics.
    J Clin Endocrinol Metab. 2024 Jun 13:dgae390. doi: 10.1210.
    

    >> Share

    
    

    
    J Diabetes Complications

46. KOVOOR JG, Rayner CK, Wu T, Jalleh RJ, et al
    Effect of lixisenatide on liquid gastric emptying in type 2 diabetes - Implications for the use of GLP-1 receptor agonists before procedures.
    J Diabetes Complications. 2024;38:108793.
    

    >> Share

    
    

    
    Metabolism

47. HANDELSMAN Y, Anderson JE, Bakris GL, Ballantyne CM, et al
    DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases.
    Metabolism. 2024 Jun 4:155931. doi: 10.1016/j.metabol.2024.155931.
    

    >> Share

    
    

    
    Nat Genet

48. OJIMA T, Namba S, Suzuki K, Yamamoto K, et al
    Body mass index stratification optimizes polygenic prediction of type 2 diabetes in cross-biobank analyses.
    Nat Genet. 2024;56:1100-1109.
    

    >> Share

    
    

    
    Obstet Gynecol

49. VALENT AM, Barbour LA
    Insulin Management for Gestational and Type 2 Diabetes in Pregnancy.
    Obstet Gynecol. 2024 Jun 13. doi: 10.1097/AOG.0000000000005640.
    

    >> Share

    
    

    
    Ophthalmology

50. ZARBIN M, Tabano D, Ahmed A, Amador M, et al
    Efficacy of Faricimab vs Aflibercept in Diabetic Macular Edema in the 20/50 or Worse Vision Subgroup in Phase 3 YOSEMITE/RHINE Trials.
    Ophthalmology. 2024 Jun 7:S0161-6420(24)00320.
    

    >> Share

    
    

    
    PLoS One

51. BAXTER F, Baillie N, Dover A, Stimson RH, et al
    A cross-sectional questionnaire study: Impaired awareness of hypoglycaemia remains prevalent in adults with type 1 diabetes and is associated with the risk of severe hypoglycaemia.
    PLoS One. 2024;19:e0297601.
    

    >> Share

    
    
52. HASEGAWA-HARUKI A, Obara K, Takaoka N, Shirai K, et al
    Hair-follicle associated pluripotent (HAP)-cell-sheet implantation enhanced wound healing in diabetic db/db mice.
    PLoS One. 2024;19:e0304676.
    

    >> Share

    
    
53. 
    Retraction: Myocardial Remodeling in Diabetic Cardiomyopathy Associated with Cardiac Mast Cell Activation.
    PLoS One. 2024;19:e0305584.
    

    >> Share

    
    
54. ALMUTAIRI FF
    The feasibility of point shear wave elastography (pSWE) in the assessment of pancreas stiffness in diabetic patients and healthy volunteers.
    PLoS One. 2024;19:e0303098.
    

    >> Share

    
    
55. LI L, Zhang M, Gu M, Li J, et al
    The causal relationship between autoimmune diseases and age-related macular degeneration: A two-sample mendelian randomization study.
    PLoS One. 2024;19:e0303170.
    

    >> Share

    
    
56. HAN Y, Wang Y, Li S, Sato K, et al
    Exploration of the shared pathways and common biomarker in adamantinomatous craniopharyngioma and type 2 diabetes using integrated bioinformatics analysis.
    PLoS One. 2024;19:e0304404.
    

    >> Share

    
    
57. YAO J, Huang W, Gao L, Liu Y, et al
    Comparative efficacy of anti-vascular endothelial growth factor on diabetic macular edema diagnosed with different patterns of optical coherence tomography: A network meta-analysis.
    PLoS One. 2024;19:e0304283.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share